[7624U]

I would agree with Doc and Trapper, I would not trust this guy Badger52.

But I would Trust the CDC stating they don't know much about COVID-19.

Other then they are very concerned about messaging, inclusion and diversity. (BECAUSE THE VIRUS CARES !) updated 2 Aug 2021.

https://www.cdc.gov/coronavirus/2019...a-covid19.html

Just a snippet

15 Priority Public Health Science Questions by Topic (as of August 2021)
Vaccines

What is the effectiveness and duration of protection afforded by vaccines against SARS-CoV-2 infection and disease in various populations and settings?

What factors contribute to COVID-19 vaccine breakthrough infections among fully vaccinated people?

How does vaccine breakthrough affect SARS-CoV-2 transmission among symptomatic and asymptomatic people?

Are COVID-19 vaccine booster doses needed for fully vaccinated people? If so, what are the recommendations for the timing and administration of booster doses?

What is the impact of COVID-19 vaccine boosters or additional doses of vaccine in immunocompromised people and other key subpopulations?

What is the impact of vaccination coverage rates on SARS-CoV-2 infections, hospitalizations, and death, particularly among those disproportionately affected by COVID-19?

How does vaccine effectiveness and protection change for different SARS-CoV-2 variants, including its impact on infections, hospitalizations, and deaths?

How does vaccine effectiveness and protection differ by age group, race and ethnicity, and people with underlying medical conditions?

What is the effectiveness of vaccination strategies with mixed vaccine products?

What interventions, program decisions, and communication approaches are most effective at increasing equitable vaccination access and coverage among various populations and settings?

What are the most effective strategies for identifying and engaging diverse populations with high levels of vaccine hesitancy to improve vaccine confidence and vaccine uptake?

What communication frames and approaches most effectively counter or prevent vaccine misinformation and disinformation, particularly in populations and settings with high numbers of unvaccinated people?

What approaches effectively identify and prioritize geographic locations where strategies should be implemented to increase equitable vaccine access?

How do socioeconomic and other social factors and determinants (e.g., internet access, physical accessibility) affect vaccine access?

How do vaccine-related questions, concerns, and misinformation change over time, and how can insights be developed for programmatic action?

What factors affect the timeliness or efficiency of COVID-19 vaccination programs?

What are the most effective approaches for building the capacity of state and local health departments and community-based organizations to address social and behavioral drivers of vaccine demand and uptake?

What is the risk for adverse events associated with COVID-19 vaccines, particularly among key sub-populations including pregnant people, adolescents and young adults, the elderly, people with underlying medical conditions, and those disproportionately affected by COVID-19?